Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio

 

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.

Through a distribution partnership with Hemostasis, LLC, the plant-based and chitosan compositions have been formulated to improve post sinus surgery recovery, comfort and healing. All products are biocompatible, dissolve naturally, require no mixing or special storage considerations and are easily conformed to fit nasal anatomy. Additionally, the sinus products minimize edema, bleeding and prevent post operative adhesions by maintaining space between the upper chambers of the nasal cavities.  

"The new offerings extend Olympus' current world-class ENT solutions to surgeons performing sinus and anterior skull base procedures and their patients," commented Perry Mykleby, Vice President of Marketing for Olympus' ENT sales. "We are pleased to collaborate with Hemostasis, a high-quality medical device manufacturer partner, to enhance patient care."

"Hemostasis is committed to providing the most comprehensive, technologically advanced ENT sinus spacing and hemostat technologies that are safe and effective for their intended use," said Hemostasis' President, Keith Roberts. "Working directly with leading physicians, we have developed practical technologies designed to optimize physician usability and efficacy, which ultimately have improved procedure outcomes and enhances overall patient care."

SOURCE Olympus America

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2019, April 30). Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio. News-Medical. Retrieved on July 13, 2024 from https://www.news-medical.net/news/20120106/Olympus-adds-dissolvable-sinus-spacing-and-hemostat-products-to-ENT-portfolio.aspx.

  • MLA

    Evident Corporation - Life Sciences. "Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio". News-Medical. 13 July 2024. <https://www.news-medical.net/news/20120106/Olympus-adds-dissolvable-sinus-spacing-and-hemostat-products-to-ENT-portfolio.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio". News-Medical. https://www.news-medical.net/news/20120106/Olympus-adds-dissolvable-sinus-spacing-and-hemostat-products-to-ENT-portfolio.aspx. (accessed July 13, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2019. Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio. News-Medical, viewed 13 July 2024, https://www.news-medical.net/news/20120106/Olympus-adds-dissolvable-sinus-spacing-and-hemostat-products-to-ENT-portfolio.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Olympus Discovery Center brings advanced microscopy to brain research